A validated stability-indicating normal phase LC method for clopidogrel bisulfate and its impurities in bulk drug and pharmaceutical dosage form

This publication has 11 references indexed in Scilit:

• Separation and determination of clopidogrel and its impurities by capillary electrophoresis
  Journal of Pharmaceutical and Biomedical Analysis, 2009
• The validation of a bioanalytical method for the determination of clopidogrel in human plasma
  Journal of Chromatography B, 2007
• Determination of clopidogrel metabolite (SR26334) in human plasma by LC–MS
  Journal of Pharmaceutical and Biomedical Analysis, 2006
• Reversed Phase Liquid Chromatographic Method for the High‐Throughput Analysis of Clopidogrel in Pharmaceutical Formulations Using a Monolithic Silica Column
  Journal of Liquid Chromatography & Related Technologies, 2005
• Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand
  Journal of Pharmaceutical and Biomedical Analysis, 2004
• Potent Mechanism-Based Inhibition of Human CYP2B6 by Clopidogrel and Ticlopidine
  The Journal of Pharmacology and Experimental Therapeutics, 2004
• Stability indicating HPTLC determination of clopidogrel bisulphate as bulk drug and in pharmaceutical dosage form
  Talanta, 2003
• Structure and Stereochemistry of the Active Metabolite of Clopidogrel
  Drug Metabolism and Disposition, 2002
• A validated LC method for the determination of clopidogrel in pharmaceutical preparations
  Journal of Pharmaceutical and Biomedical Analysis, 2002
• Assay method for the carboxylic acid metabolite of clopidogrel in human plasma by gas chromatography–mass spectrometry
  Journal of Chromatography B: Biomedical Sciences and Applications, 1998